NewsRx

Search our medical news database

Cancer Gene Therapy

Transfer of TNF(alpha) Gene Restores Apoptotic Program

Published in Gene Therapy Weekly, April 1st, 1996

Retroviral-mediated transfer of a tumor necrosis factor (alpha) (TNF(alpha)) gene into human cancer cells restores an apoptotic cell death program and induces a bystander-killing effect.

TNF(alpha) is a monocyte-derived cytotoxin with contrasting effects. It protects against infection and can induce tumor regression, but it also can cause cachexia, septic shock, and inflammatory disease. Findings suggest that this cytokine has potential as an anticancer agent, but its clinical use has been limited by toxic effects associated with systemic administration.

Anna Gillio Tos et al. investigated the anticancer potential of retroviral-mediated gene...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook